Results
|
|
42701.
|
|
|
|
42702.
|
|
|
|
42703.
|
|
|
|
42704.
|
|
|
|
42705.
|
|
|
|
42706.
|
|
|
|
42707.
|
|
|
|
42708.
|
|
|
|
42709.
|
|
|
|
42710.
|
|
|
|
42711.
|
|
|
|
42712.
|
|
|
|
42713.
|
|
|
|
42714.
|
|
|
|
42715.
|
|
|
|
42716.
|
|
|
|
42717.
|
|
|
|
42718.
|
Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma. [electronic resource] by
- Murray, J L
- Kleinerman, E S
- Jia, S F
- Rosenblum, M G
- Eton, O
- Buzaid, A
- Legha, S
- Ross, M I
- Thompson, L
- Mujoo, K
- Rieger, P T
- Saleh, M
- Khazaeli, M B
- Vadhan-Raj, S
Producer: 19970131
In:
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy vol. 19
Availability: No items available.
|
|
|
42719.
|
|
|
|
42720.
|
|